Nanoparticle Cytometrics: a quantitative analysis of the toxic effect of nanoparticles

Lead Research Organisation: University of Leeds
Department Name: Institute of Materials Research

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
 
Description Key findings
1) We have used an electron microscope to measure the dispersion of nano particles in liquids (by rapidly freezing the liquid with the nano particles trapped in the suspension). This has enabled measurement of nano particle clustering in challenging liquids such as cell culture media which contain other suspended solids. Using the method we can establish whether individual or groups of nano particles are delivered to cells for toxicity texting or cell uptake studies.

2) We have used electron microscopy to count the number of fluorescent nano particles taken up by cells. By combining this count with the fluorescence intensity measured from many cells in a population we can estimate the average number and range of nano particles taken up by each cell across a cell population. This measure of dose will help us to predict the potential efficacy of a nano particle based medicine.

3) We have used electron microscopy to confirm that nano particles which fluoresce with different colours can be taken up separately by cells. This is a key step in a new method we have developed to accurately mark and track live cells over several hours.

4) We have assessed the toxic potential of semiconductor particles that fluoresce (and can be used as optical biomarkers) as a function of the surface charge on the particles. We suggest that negatively charge particles produce the most efficient uptake with lowest toxicity.
Exploitation Route Others will use the microscopy techniques developed in this work for similar nano toxicology and nano medicine investigations.
Sectors Healthcare,Pharmaceuticals and Medical Biotechnology

 
Description So far our findings have been communicated by publication, at academic conferences (including for invited talks) and by presentation to regulatory bodies (the EU grant meetings) and external companies, such as AstraZeneca. We would expect other researchers to use the microscopy techniques developed in this work for similar nano toxicology and nano medicine investigations. The post-doctoral researcher employed on the contract has been awarded an independent research fellowship (AXA award and now a University Academic Fellowship).
First Year Of Impact 2011
Sector Healthcare,Pharmaceuticals and Medical Biotechnology
Impact Types Societal